A Clinical Trial to Assess the Efficacy and Safety of Subjects With Dry Eye Disease
Status:
COMPLETED
Trial end date:
2024-06-11
Target enrollment:
Participant gender:
Summary
A Randomized, Double-Masked, Vehicle-Controlled Parallel Group Clinical Trial to Assess Efficacy and Safety of 0.25% Reproxalap Ophthalmic Solution Compared to Vehicle in Subjects with Dry Eye Disease